BIJUVA (estradiol-progesterone)

SELF ADMINISTRATION - Oral

Indications for Prior Authorization:
  • Treatment of moderate to severe vasomotor symptoms due to menopause
Patients must meet the following criteria for the indication(s) above:
  • Patient has a diagnosis of vasomotor symptoms associated with menopause, AND
  • Patient has completed a trial of and had an inadequate response to or intolerance to oral estradiol 1 mg tablets and progesterone 100 mg capsules used concomitantly as separate products as documented in chart notes
Dosing:
  • One 1 mg/100 mg capsule orally each evening with food
Approval: 
  • 1 year

Last review date: October 15, 2019